Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ase Industrial Holding Ltd ADR (NY: ASX )

9.960 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25
Open 9.960
Bid (Size) 9.960 (1)
Ask (Size) 10.20 (4)
Prev. Close 9.960
Today's Range 9.960 - 9.960
52wk Range 7.200 - 12.86
Shares Outstanding 4,408,018,732
Dividend Yield 5.73%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st
Global Uranium invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Apple's Taiwanese Chip Supplier ASE Tech Clocks Modest Q2 Growth In Revenues
ASE Technology (ASX) reported 2.9% Y/Y net revenue growth to $4.35B, missing analyst estimate. Its Apple chip supplier revenue grew 5.6% Q/Q. 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain

Performance

YTD
+9.69%
+9.69%
1 Month
-12.09%
-12.09%
3 Month
-3.58%
-3.58%
6 Month
+5.06%
+5.06%
1 Year
+24.03%
+24.03%

More News

Read More
Alterity Therapeutics to Present at MST Financial Webinar
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Discover the Hidden Gem in Chip Manufacturing Stocks
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia, Apple Supplier TSMC And Other US-Listed Taiwan Stocks Trading Lower In Pre-Market After Biden Quits Presidential Race
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
All 6 Semiconductor Segments Down 11%, On Average, This Week: Time To Buy In?
Via Talk Markets
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ISE Labs Expands Capabilities, Doubles Lab Space with Opening of Second Silicon Valley Location
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
4 Of 6 Semiconductor Portfolios Outperformed The Nasdaq This Week
Via Talk Markets
Topics Economy
Exposures Economy
OTC Markets Group Welcomes Sovereign Metals Limited to OTCQX
From OTC Markets
Via GlobeNewswire
Pure-Play Semiconductor Assembly, Test And Packaging Portfolio Up 17% In June; Now Up 20.5% YTD
Via Talk Markets
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
From CSL Behring
Via GlobeNewswire
Unlocking ASX Trading Success: ASX LIMITED - ASX Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2023
From ASE Technology Holding Co., Ltd.
Via Business Wire
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Small-Cap Growth Virtual Investor Conference Agenda Announced for June 13th
From Virtual Investor Conferences
Via GlobeNewswire
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Via Benzinga
If You Can Only Buy One Semiconductor Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Unlocking ASX Trading Success: ASX LMITED - ASX Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE Introduces powerSiP™ for Transformative Power Delivery That Increases Power Efficiencies by 50% in AI and Data Center Applications
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
ASX Stock Analysis & Elliott Wave Technical Forecast - Friday, May 24
Via Talk Markets
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
From MatrixCare
Via GlobeNewswire
OTC Markets Group Welcomes Neometals Ltd. to OTCQX
From OTC Markets
Via GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.